1-20 of 62
Tong Wu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Efficacy and Safety of Olverembatinib Combined with Monoclonal Antibodies As Salvage Therapy for RR B ALL with ABL1 Fusion Gene Positive

Yuehui Lin, Tong Wu, Dan Liu, Chunrong Tong
Journal: Blood
Blood (2023) 142 (Supplement 1): 5896.
https://doi.org/10.1182/blood-2023-186153
Published: 2023
Journal Articles

CD7 Chimeric Antigen Receptor T-Cell Therapy Bridging to Allogeneic Hematopoietic Stem Cell Transplantation Remarkably Improved Long-Term Disease-Free Survival in Refractory/Relapsed T-Cell Acute Lymphoblastic Leukemia/Lymphoma

Zhihui Li, Qinlong Zheng, Keyan Yang, Teng Xu, Lei Wang, Xianxuan Wang, Xiaopei Wen, Yanzhi Song, Yongqiang Zhao, Tong Wu
Journal: Blood
Blood (2023) 142 (Supplement 1): 239.
https://doi.org/10.1182/blood-2023-180834
Published: 2023
Journal Articles

A Compilation of Experiences in Utilizing CAR-T Cell Therapy for Richter's Transformation

Shaomei Feng, Teng Xu, Haidi Liu, Peihao Zheng, Lixia Ma, Hui SHI, Tong Wu, Fan Yang, Kai HU, Xiaoyan Ke
Journal: Blood
Blood (2023) 142 (Supplement 1): 4638.
https://doi.org/10.1182/blood-2023-182797
Published: 2023
Journal Articles

Clinical Features of Myeloid Neoplasms with Germline GATA2 Mutations–a Systematic Review of Clinical Studies Retrieved through Extensive Searching

Yanzhi Song, Erhui Yuan, Zhanxiang Liu, Tong Wu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6498.
https://doi.org/10.1182/blood-2023-186383
Published: 2023
Journal Articles

Good Survival of CAR-T Cell Therapy Bridging to Allo-HSCT for Relapsed/Refractory Ph-Positive B-Cell Acute Lymphoblastic Leukemia

Zhanxiang Liu, Tong Wu, Yanzhi Song, Erhui Yuan, Qishu Qin, Qi Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 7043.
https://doi.org/10.1182/blood-2023-187988
Published: 2023
Journal Articles

Clinical Implications of Germline Predisposition Gene Variants in Patients with Refractory or Relapsed B Acute Lymphoblastic Leukemia

Zhao Defeng, Tong Wu, Chunrong Tong, Lin Yuehui, Qinlong Zheng
Journal: Blood
Blood (2023) 142 (Supplement 1): 1612.
https://doi.org/10.1182/blood-2023-181512
Published: 2023
Journal Articles

Trametinib Maintenance in Patients with RAS Mutated Hematologic Malignancy Undergoing Allogeneic Haematopoietic Stem-Cell Transplantation: A Retrospective Transplant Study

Zhihui Li, Teng Xu, Xianxuan Wang, Xiaopei Wen, Lei Wang, Jingjing Wang, Tong Wu
Journal: Blood
Blood (2023) 142 (Supplement 1): 2212.
https://doi.org/10.1182/blood-2023-181425
Published: 2023
Journal Articles

Molecular Biomarker Analyses for Exploring the Therapeutic Mechanism of Lemzoparlimab and Azacitidine (AZA) in Newly Diagnosed Higher Risk Myelodysplastic Syndrome (HR-MDS)

Zhijian Xiao, Chunkang Chang, Qiubai Li, Xiaojing Yan, Tiejun Qin, Hongyan Tong, Yu Zhang, Min Dai, Yanjie He, Jianyu Weng, Jian Li, Sujun Gao, Rong Fu, Xudong Wei, Aili He, Jinhai Ren, Tong Wu, Xin Du, Yanni Zhang, Ke Xu, Zhengyi Wang, Michelle Yang, Andrew Zhu
Journal: Blood
Blood (2022) 140 (Supplement 1): 8821–8822.
https://doi.org/10.1182/blood-2022-163880
Published: 2022
Journal Articles

CD58 Could be As a Leukemic Marker in Relapsed/Refractory B-ALL Patients after Multiline Therapies

Xinjian Yu, Pan Li, Heyuan Feng, Jian Kang, Yafeng Li, Xichang Zheng, Tong Wu, Shuangyou Liu
Journal: Blood
Blood (2022) 140 (Supplement 1): 1043–1044.
https://doi.org/10.1182/blood-2022-164946
Published: 2022
Journal Articles

Profiles of Germline Predisposition Gene Variants in Hematologic Disorders and Its Impact on Prognosis of Allogeneic Hematopoietic Stem Cell Transplantation

Zhihui Li, Keyan Yang, Qinlong Zheng, Xianxuan Wang, Fan Wu, Jing Li, Xiaopei Wen, Caiyan Zhang, Jingjing Wang, Yanzhi Song, Yongqiang Zhao, Tong Wu
Journal: Blood
Blood (2022) 140 (Supplement 1): 7693–7694.
https://doi.org/10.1182/blood-2022-166695
Published: 2022
Journal Articles

Subsequent Secondary CAR-T Cell Therapy Was Superior to Chemotherapy in Patients with Refractory/Relapsed B-Cell Lymphoma after Failure of Anti-CD19 CAR-T Cell Therapy

Fan Yang, Rui Liu, Teng Xu, Peihao Zheng, Shaomei Feng, Yuelu Guo, Lixia Ma, Hui SHI, Biping Deng, Xiaoyan Ke, Tong Wu, Kai Hu
Journal: Blood
Blood (2022) 140 (Supplement 1): 10384–10385.
https://doi.org/10.1182/blood-2022-164446
Published: 2022
Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation with Conditioning Including Donor Humanized CAR-T Cells for Refractory/Relapsed B-Cell Non-Hodgkin Lymphoma and Multiple Myeloma

Fan Yang, Hui Shi, Yang Lei, Ruiting Li, Teng Xu, Biping Deng, Tong Wu, Xiaoyan Ke, Kai Hu
Journal: Blood
Blood (2021) 138 (Supplement 1): 557.
https://doi.org/10.1182/blood-2021-146767
Published: 2021
Journal Articles

Long-Term Follow-up of Allogeneic Hematopoietic Stem Cell Transplantation after Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Zhihui Li, Qinlong Zheng, Fan Wu, Caiyan Zhang, Teng Xu, Yongqiang Zhao, Yanzhi Song, Tong Wu
Journal: Blood
Blood (2021) 138 (Supplement 1): 1820.
https://doi.org/10.1182/blood-2021-150192
Published: 2021
Journal Articles

Allogeneic-Hematopoietic Stem Cell Transplantation Is Effective and Safe for Relapsed/ Refractory B-ALL Patients Who Cannot Get Remission or MRD Negative after CART Treatment

Yanzhi Song, Zhihui Li, Yongqiang Zhao, Fan Yang, Erhui Yuan, Qi Wang, Tong Wu
Journal: Blood
Blood (2021) 138 (Supplement 1): 1843.
https://doi.org/10.1182/blood-2021-146357
Published: 2021
Journal Articles

Secondary Humanized CAR T Cells Salvage Therapy Improves Survival of R/R DLBCL Patients Failed to Murine CD19-CAR T Cells Therapy

Hui SHI, Kai Hu, Xiaoyan Ke, Tong Wu
Journal: Blood
Blood (2021) 138 (Supplement 1): 4836.
https://doi.org/10.1182/blood-2021-150108
Published: 2021
Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for Refractory/Relapsed T-Cell Acute Lymphoblastic Leukemia/Lymphoma after Donor-Derived CD7- Chimeric Antigen Receptor T-Cell Therapy

Zhihui Li, Xiaojuan Peng, Xiaopei Wen, Jing Li, Yanzhi Song, Teng Xu, Tong Wu
Journal: Blood
Blood (2021) 138 (Supplement 1): 3922.
https://doi.org/10.1182/blood-2021-149558
Published: 2021
Journal Articles

Better Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation with Reduced-Intensity Conditioning in Elderly Patients with Hematological Malignancies

Yongqiang Zhao, Yanzhi Song, Fan Yang, Feifei Li, Dongfang Yang, Tong Wu
Journal: Blood
Blood (2021) 138 (Supplement 1): 4864.
https://doi.org/10.1182/blood-2021-149871
Published: 2021
Journal Articles

Excellent Outcomes of the Second Allogeneic Hematopoietic Stem Cell Transplantation in Hematological Malignancies with Reduced Toxicity Conditioning and Donor Change

Yongqiang Zhao, Yanzhi Song, Zhihui Li, Fan Yang, Feifei Li, Dongfang Yang, Tong Wu
Journal: Blood
Blood (2021) 138 (Supplement 1): 4891.
https://doi.org/10.1182/blood-2021-150087
Published: 2021
Journal Articles

Immunodeficiency Genes Are Associated with EBV Positive Malignancies and Hemophagocytic Lymphohistiocytosis That Can be Cured By Allogeneic Hematopoietic Stem Cell Transplantation

Yanzhi Song, Caiyan Zhang, Zhihui Li, Erhui Yuan, Qishu Qin, Qinlong Zheng, Tong Wu
Journal: Blood
Blood (2021) 138 (Supplement 1): 4908.
https://doi.org/10.1182/blood-2021-149918
Published: 2021
Journal Articles

Auto Hematopoietic Stem Cell Transplantation Combined with Another Target Humanized CAR-T Cells for Refractory/Relapsed B-Cell Non-Hodgkin Lymphoma after Failure of Murinized CD19-CAR-T Therapy

Kai Hu, Fan Yang, Rui Liu, Teng Xu, Peihao Zheng, Shaomei Feng, Yuelu Guo, Hui Shi, Biping Deng, Xiaoyan Ke, Tong Wu
Journal: Blood
Blood (2021) 138 (Supplement 1): 657.
https://doi.org/10.1182/blood-2021-146801
Published: 2021